PEPTIDES ARE BACK! Following the withdrawal of nominations, the FDA will now remove 12 peptides from Category 2 and bring them before the Pharmacy Compounding Advisory Committee (PCAC) beginning July 23 24, 2026. Acheter Dihexa CAS 1401708 83 5 Rexar EllieMD Dihexa After being placed into FDA Category 2 in 2023, several widely discussed peptides faced restricted pathways for regulated compounding. This shift pushed demand toward unregulated markets and created significant uncertainty across the